Jasper Therapeutics, Inc
Fundamentals
Oldest to newest| Line | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating income | −$36.8M | −$51.2M | −$68.9M | −$76.2M | −$83.9M |
| Net income | −$30.6M | −$37.7M | −$64.5M | −$71.3M | −$75.80 |
| Operating cash flow | −$33.7M | −$45.9M | −$52.1M | −$62.6M | −$77.2M |
| Cash | $84.7M | $38.3M | $86.9M | $71.6M | $28.7M |
| Shares outstanding | 37.9M | 3.8M | 11.2M | 15.0M | 28.0M |